ECTE - Echo Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 569.14k
Enterprise Value 33.5M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.68

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2015
Most Recent Quarter (mrq)Sep 30, 2016


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-359.77%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-12.5M
Diluted EPS (ttm)-1.1020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)172.72k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)3.52M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.05
Book Value Per Share (mrq)-0.55

Cash Flow Statement

Operating Cash Flow (ttm)-4.82M
Levered Free Cash Flow (ttm)-910.41k

Trading Information

Stock Price History

Beta (3Y Monthly) 2.48
52-Week Change 3-40.00%
S&P500 52-Week Change 37.73%
52 Week High 30.0500
52 Week Low 30.0000
50-Day Moving Average 30.0100
200-Day Moving Average 30.0100

Share Statistics

Avg Vol (3 month) 318.83k
Avg Vol (10 day) 38.95k
Shares Outstanding 513.3M
Float 11.75M
% Held by Insiders 11.72%
% Held by Institutions 10.10%
Shares Short (Jun 15, 2016) 4273.27k
Short Ratio (Jun 15, 2016) 43.4
Short % of Float (Jun 15, 2016) 42.40%
Short % of Shares Outstanding (Jun 15, 2016) 42.40%
Shares Short (prior month May 13, 2016) 4202.15k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/10
Last Split Date 3Jun 7, 2013